Non-invasive forearm ischemia-reperfusion injury and low flow induced vascular dysfunction models provide methods to evaluate vascular function. The role of oestrogen, an endogenous anti-oxidant on recovery from ischemia-reperfusion injury has not been evaluated nor has the impact of prolonged low flow on vascular function been established. Eight healthy women (33±10 yr) attended the lab during the follicular, ovulatory and mid-luteal phases of their menstrual cycles. After 30 minutes of rest, brachial artery vascular function was assessed by ultrasound measurements of diameter changes during 5 minutes of forearm ischemia and 3 minutes after. Subsequently, a 20-minute forearm ischemia period was completed. Further, vascular function assessments were completed 15, 30 and 45 minutes into recovery. Flow-mediated dilation, low-flow-mediated constriction, and reactive hyperaemia proximal to the area of ischemia were determined. Flow-mediated dilation was reduced at 15 minutes of recovery but recovered at 30 and 45 minutes (PRE: 7.1±1.0%, POST15:4.5±0.6%, POST30:5. 5±0.7% POST45:5.9±0.4%, p<0.01). Conversely, low-flow mediated constriction increased (PRE: ？1.3±0.4%, POST15: ？3.3±0.6%, POST30: ？2.5±0.5% POST45: ？1.5±0.12%, p<0.01). Reactive hyperaemia was reduced throughout recovery (p<0.05). Data were unaffected by menstrual phase. Prolonged low flow altered vascular function and may relate as much to increased vasoconstriction as with decreased vasodilation. Reductions in anterograde shear and greater retrograde shear likely modulate the brachial artery response, but the reduced total shear also plays an important role. The data suggest substantial alterations in vascular function proximal to areas of ischemia with potential clinical implications following reperfusion.
References
[1]
Pleiner J, Schaller G, Mittermayer F, Marsik C, MacAllister RJ, et al. (2008) Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis 197: 383–391 doi:10.1016/j.atherosclerosis.2007.06.011.
[2]
Loukogeorgakis SP, Panagiotidou AT, Yellon DM, Deanfield JE, MacAllister RJ (2006) Postconditioning protects against endothelial ischemia-reperfusion injury in the human forearm. Circulation 113: 1015–1019 doi:10.1161/CIRCULATIONAHA.105.590398.
[3]
Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, et al. (2005) Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol 46: 450–456 doi:10.1016/j.jacc.2005.04.044.
[4]
Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, et al. (2001) Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 103: 1624–1630.
[5]
Broadhead MW, Kharbanda RK, Peters MJ, MacAllister RJ (2004) KATP channel activation induces ischemic preconditioning of the endothelium in humans in vivo. Circulation 110: 2077–2082 doi:10.1161/01.CIR.0000144304.91010.F0.
[6]
Gori T, Sicuro S, Dragoni S, Donati G, Forconi S, et al. (2005) Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study. Circulation 111: 742–746 doi:10.1161/01.CIR.0000155252.23933.2D.
[7]
Malek AM, Alper SL, Izumo S (1999) Hemodynamic shear stress and its role in atherosclerosis. JAMA 282: 2035–2042.
[8]
Devan AE, Umpierre D, Harrison ML, Lin H-F, Tarumi T, et al. (2011) Endothelial ischemia-reperfusion injury in humans: association with age and habitual exercise. Am J Physiol Heart Circ Physiol 300: H813–9 doi:10.1152/ajpheart.00845.2010.
[9]
Okorie MI, Bhavsar DD, Ridout D, Charakida M, Deanfield JE, et al. (2011) Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore. Eur Heart J 32: 1266–1274 doi:10.1093/eurheartj/ehr041.
[10]
Fadini GP, De Kreutzenberg S, Albiero M, Coracina A, Pagnin E, et al. (2008) Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 28: 997–1004.
Thijssen DHJ, Black M a, Pyke KE, Padilla J, Atkinson G, et al. (2011) Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 300: H2–12 doi:10.1152/ajpheart.00471.2010.
[13]
Gori T, Grotti S, Dragoni S, Lisi M, Di Stolfo G, et al. (2010) Assessment of vascular function: flow-mediated constriction complements the information of flow-mediated dilatation. Heart 96: 141–147 doi:10.1136/hrt.2009.167213.
[14]
Spieker LE, Lüscher TF, Noll G, Luscher TF (2003) ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humans. J Cardiovasc Pharmacol 42: 315–318.
[15]
Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, et al. (2008) Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol 51: 1953–1958 doi:10.1016/j.jacc.2008.01.049.
[16]
Rakobowchuk M, Harris E, Taylor A, Baliga V, Cubbon RM, et al. (2012) Heavy and moderate interval exercise training alters low-flow-mediated constriction but does not increase circulating progenitor cells in healthy humans. Exp Physiol 97: 375–385 doi:10.1113/expphysiol.2011.062836.
[17]
Gori T, Muxel S, Damaske A, Radmacher M-C, Fasola F, et al. (2012) Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. Eur Heart J 33: 363–371 doi:10.1093/eurheartj/ehr361.
[18]
Weissgerber TL, Davies G a L, Tschakovsky ME (2010) Low flow-mediated constriction occurs in the radial but not the brachial artery in healthy pregnant and nonpregnant women. J Appl Physiol 108: 1097–1105 doi:10.1152/japplphysiol.00815.2009.
[19]
Pedersen CM, Barnes G, Schmidt MR, B？tker HE, Kharbanda RK, et al. (2012) Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man. Eur Heart J 33: 1920–1927 doi:10.1093/eurheartj/ehr380.
[20]
Pyke KE, Tschakovsky ME (2007) Peak vs. total reactive hyperemia: which determines the magnitude of flow-mediated dilation? J Appl Physiol 102: 1510–1519 doi:10.1152/japplphysiol.01024.2006.
[21]
Jiang B, Seddon M, Fok H, Donald A, Chowienczyk P (2011) Flow-mediated dilation of the radial artery is offset by flow-induced reduction in transmural pressure. Hypertension 57: 1145–1150 doi:10.1161/HYPERTENSIONAHA.110.163113.
[22]
Loukogeorgakis SP, Van den Berg MJ, Sofat R, Nitsch D, Charakida M, et al. (2010) Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation 121: 2310–2316 doi:10.1161/CIRCULATIONAHA.108.814731.
